Corbus Pharmaceuticals Holdings (CRBP) Retained Earnings (2013 - 2025)
Corbus Pharmaceuticals Holdings' (CRBP) quarterly Retained Earnings came in at $703.0 million in Q4 2025, up 2008425.71% year-on-year from N/an in Q4 2024, and up 23432900.0% quarter-over-quarter from -$3000.0 in Q3 2025.
Corbus Pharmaceuticals Holdings (CRBP) Retained Earnings (2013 - 2025) Analysis & Trends
Corbus Pharmaceuticals Holdings' Retained Earnings history runs 13 years deep, the most recent figure standing at $703.0 million for Q4 2025.
- On a quarterly basis, Retained Earnings rose 2008425.71% year-over-year to $703.0 million in Q4 2025; TTM through Dec 2025 was $703.0 million, a 2008425.71% increase from a year earlier, with the FY2025 full-year figure at $703.0 million, up 2008425.71% from the prior year.
- Retained Earnings improved to $703.0 million in Q4 2025 per CRBP's latest filing, from -$3000.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $703.0 million in Q4 2025 and bottomed at -$453.6 million in Q2 2024.
- The 5-year median for Retained Earnings is -$15983.5 (2021), against an average of $28.4 million.
- Biggest YoY gain for Retained Earnings was 7687131.74% in 2024; the steepest drop was 647759.26% in 2024.
- Year by year, Retained Earnings stood at -$62445.0 in 2021, then jumped by 681013.38% to $425.2 million in 2022, then tumbled by 100.0% to -$1000.0 in 2023, then jumped by 3600.0% to $35000.0 in 2024, then jumped by 2008425.71% to $703.0 million in 2025.
- Per Business Quant, the three latest CRBP Retained Earnings figures stand at $703.0 million (Q4 2025), -$3000.0 (Q3 2025), and -$39000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Corbus Pharmaceuticals Holdings | 164.14 Mn | 136.33 Mn | - | 702.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 702.98 Mn |
| Sep 30, 2025 | -3,000.00 |
| Jun 30, 2025 | -39,000.00 |
| Mar 31, 2025 | -23,000.00 |
| Dec 31, 2024 | 35,000.00 |
| Sep 30, 2024 | 617.65 Mn |
| Jun 30, 2024 | -453.58 Mn |
| Mar 31, 2024 | -443.58 Mn |
| Dec 31, 2023 | -1,000.00 |
| Sep 30, 2023 | -8,035.00 |
| Jun 30, 2023 | -418.61 Mn |
| Mar 31, 2023 | -68,469.00 |
| Dec 31, 2022 | 425.20 Mn |
| Sep 30, 2022 | 423.34 Mn |
| Jun 30, 2022 | -119,320.00 |
| Mar 31, 2022 | -359.17 Mn |
| Dec 31, 2021 | -62,445.00 |
| Sep 30, 2021 | -8,967.00 |
| Jun 30, 2021 | -337.30 Mn |
| Mar 31, 2021 | 411.69 Mn |